CYP2E1

Revision as of 19:37, 7 January 2009 by Swilliams (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:PBB

WikiDoc Resources for CYP2E1

Articles

Most recent articles on CYP2E1

Most cited articles on CYP2E1

Review articles on CYP2E1

Articles on CYP2E1 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on CYP2E1

Images of CYP2E1

Photos of CYP2E1

Podcasts & MP3s on CYP2E1

Videos on CYP2E1

Evidence Based Medicine

Cochrane Collaboration on CYP2E1

Bandolier on CYP2E1

TRIP on CYP2E1

Clinical Trials

Ongoing Trials on CYP2E1 at Clinical Trials.gov

Trial results on CYP2E1

Clinical Trials on CYP2E1 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on CYP2E1

NICE Guidance on CYP2E1

NHS PRODIGY Guidance

FDA on CYP2E1

CDC on CYP2E1

Books

Books on CYP2E1

News

CYP2E1 in the news

Be alerted to news on CYP2E1

News trends on CYP2E1

Commentary

Blogs on CYP2E1

Definitions

Definitions of CYP2E1

Patient Resources / Community

Patient resources on CYP2E1

Discussion groups on CYP2E1

Patient Handouts on CYP2E1

Directions to Hospitals Treating CYP2E1

Risk calculators and risk factors for CYP2E1

Healthcare Provider Resources

Symptoms of CYP2E1

Causes & Risk Factors for CYP2E1

Diagnostic studies for CYP2E1

Treatment of CYP2E1

Continuing Medical Education (CME)

CME Programs on CYP2E1

International

CYP2E1 en Espanol

CYP2E1 en Francais

Business

CYP2E1 in the Marketplace

Patents on CYP2E1

Experimental / Informatics

List of terms related to CYP2E1

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Cytochrome P450 2E1 (abbreviated CYP2E1, EC 1.14.14.1), a member of the cytochrome P450 mixed-function oxidase system, is involved in the metabolism of xenobiotics in the body. While it is involved only in the oxidative metabolism of a small range of substrates (mostly small polar molecules), there are many important drug interactions mediated by CYP2E1.

CYP2E1 Ligands

Selected inducers, inhibitors and substrates of CYP2E1[1]
Substrates Inhibitors Inducers
Often mentioned: [2]

Other:

Strong: [3]

unspecified:

Regulation of CYP2E1

Within one day of birth, the rat hepatic CYP2E1 gene is activated transcriptionally. CYP2E1 expression is easily inducible. It seems that there exist two stages of induction, a posttranslational mechanism for increased protein stability at low levels of ethanol, and an additional transcriptional induction at high levels of ethanol[4]

See also

References

  1. Where classes of agents are listed, there may be exceptions within the class
  2. Mentioned both in the reference named FASS and were previously mentioned in Wikipedia. Further contributions may follow other systems
  3. Swedish environmental classification of pharmaceuticals Facts for prescribers (Fakta för förskrivare)
  4. Charles S. Lieber. 1999. Microsomal Ethanol-Oxidizing System (MEOS) The First 30 Years (1968-1998)-A Review. Alcoholism: Clinical and Experimental Research 23(6):991-1007

Further reading

  • Smith G, Stubbins MJ, Harries LW, Wolf CR (1999). "Molecular genetics of the human cytochrome P450 monooxygenase superfamily". Xenobiotica. 28 (12): 1129–65. PMID 9890157.
  • Kessova I, Cederbaum AI (2003). "CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury". Curr. Mol. Med. 3 (6): 509–18. doi:10.2174/1566524033479609. PMID 14527082.

Template:SIB

Template:WH Template:WS